Corrigendum to “Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys” [EBioMedicine 2020; 59:102944]
Guardado en:
Autores principales: | Diana Alarcón-Arís, Rubén Pavia-Collado, Lluis Miquel-Rio, Valentín Coppola-Segovia, Albert Ferrés-Coy, Esther Ruiz-Bronchal, Mireia Galofré, Verónica Paz, Leticia Campa, Raquel Revilla, Andrés Montefeltro, Jeffrey H. Kordower, Miquel Vila, Francesc Artigas, Analia Bortolozzi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50d955548e494d92a77f88a6b0808f54 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
por: Frank Y. Shan, et al.
Publicado: (2021) -
In situ architecture of neuronal α-Synuclein inclusions
por: Victoria A. Trinkaus, et al.
Publicado: (2021) -
α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
por: Hazem Abdelkarim, et al.
Publicado: (2018) -
Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
por: Jennifer A. Macdonald, et al.
Publicado: (2021) -
Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson’s disease using electrophysiological measurements of visual processing
por: Freja Gam Østergaard, et al.
Publicado: (2020)